8.1 With respect to patent rights that are granted exclusively to licensees under this agreement, LICENSEE has the right to immediately pursue any infringement of that patent of which HARVARD is aware or will be informed of any infringement of those patents. Before LICENSEE initiates legal action regarding the infringement of such patents, LICENSEE will carefully consider HARVARD`s views and the potential impact on the public interest in deciding whether or not to file a complaint. (e) In all sub-licences granted by LICENSEE under this sub-licence, LICENSEE must provide for the obligation that the sublicensing make its best efforts to bring the subject matter of the sublicensing into commercial operation as quickly as possible. LICENSEE also finds in these sublicensings that these sublicensings are subject to and subject to the terms of this agreement, unless: (i) the sublicensing is not allowed to grant additional sublicensing; and (ii) the NET SALES royalty rate that the licensee pays to the licensee. Copies of all sublicensing contracts must be provided to HARVARD without delay. There is always a risk that either party will commit a substantial breach of the agreement or go bankrupt, and that clause deals with the situation. It also includes the possibility of a case of force majeure and allows it to be terminated if this force majeure event lasts for some time – in our case, 90 days, but this period could be extended. It is not always easy to clean up a “substantial” violation that is not essential and, if necessary, mention of a “substantial or permanent” violation of item 18.104.22.168.10 NO-ROYALTY SUBLICENSE INCOME: sublicensing charges, sublicensing maintenance fees, sublicensing milestone payments and non-payment of similar licenses by subcontractors under this agreement may be omitted. LICENSEE seeks an exclusive license in the territory to practice the aforementioned invention, which falls under BREVET RIGHTS in the United States and in certain countries, and to produce, use and sell on the commercial market products manufactured under this treaty, and HARVARD has the authority to grant it to LICENSEE in accordance with the provisions of this agreement. An exclusive commercial license under PATENT RIGHTS and a license for the use of biological materials for the manufacture and manufacture, use and use, sale and sale of the products granted and the exercise of processes granted for the life of patent rights. 7.2 HARVARD and LICENSEE cooperate fully in the preparation, filing, monitoring and maintenance of PATENT RECHTEN and all patents and patent applications authorized by LICENSEE under this agreement, and execute all documents and instruments, or require HARVARD members to execute these documents and instruments so that PATENT applications and PATENTs from HARVARD are filed in each country. , to follow and maintain.
Each party immediately informs the other party of any issues brought to its attention that may affect the preparation, filing, prosecution or maintenance of these patent applications or patents. In particular, LICENSEE must immediately notify HARVARD whether LICENSEE or an AFFILIATE or licensee (or option holder) is not classified as a “small entity” as provided by the U.S. Patent and Trademark Office. 5.1 Prior to the signing of this agreement, LICENSEE provided Harvard with a written research and development plan under which LICENSEE plans to commercially exploit the purpose of the licensing granted under this agreement after the implementation of this agreement.